Serena Williams, GLP-1s, and the Risk of Normalisation
Serena Williams’ admission of GLP-1 use post-pregnancy reframes weight loss drugs in public discourse—raising questions of access, safety, and clinical readiness.
Read moreSerena Williams’ admission of GLP-1 use post-pregnancy reframes weight loss drugs in public discourse—raising questions of access, safety, and clinical readiness.
Read moreA consumer report has cast doubt on popular sunscreens, but the TGA urges confidence in Australia’s rigorous SPF testing standards. We explore the facts behind the claims.
Read moreThe Albanese Government’s $8.5B Medicare plan expands bulk-billing incentives and aims to boost GP access while raising questions about viability for practices.
Read moreWith the US withdrawing from the WHO, global health coordination faces uncertainty. What does this mean for Australia’s disease preparedness, partnerships, and security?
Read moreThe NSW public psychiatry system is in crisis, with mass resignations exposing deep flaws in pay, staffing, and mental health care. What happens next could shape the future of psychiatric services across Australia.
Read moreThis article explores the upcoming changes to paracetamol access in Australia, including pack size restrictions and blister packaging requirements. It discusses the implications for healthcare professionals, the importance of patient education, and the need for ongoing vigilance in minimizing paracetamol-related..
Read moreSouth Australia's groundbreaking legislation banning social media for children under 16 aims to protect mental health but raises concerns about support access. Medical professionals play a crucial role in navigating this evolving landscape.
Read moreExplore the complexities of SCS for chronic pain management. Learn about the TGA review, patient selection, and the importance of evidence-based approaches in this evolving field.
Read moreAustralia faces a growing burden of macular disease, impacting millions and straining healthcare. Learn about AMD, DR, early detection, and the Macular Disease Foundation's role in addressing this challenge.
Read more